Scientist.com

Scientist.com is proud to be recognized as a San Diego Business Impact Honoree by San Diego Regional Economic Development Corporation and JPMorganChase for our continued efforts to support meaningful growth, create jobs, and build a stronger economic future here in San Diego. 😎  More than a third of our company's global workforce is based in San Diego, the company invested in a brand new Solana Beach office in the newly constructed Sandbox building two years ago, and we cultivate our workforce from the ground up, offering in-person, onsite internships to students from local colleges, including UC San Diego, San Diego State University, and California State University San Marcos; plus, we've hired numerous developers directly out of San Diego coding bootcamps. The result: Scientist.com is actively developing local early-career talent in the region's most future-facing jobs—applied AI and software in life sciences—that San Diego will need in the coming years. Congratulations to all of our fellow honorees for making an impact across our region and creating meaningful economic growth.

Join Axcelead Drug Discovery Partners, Inc. for the upcoming webinar, "Enhancing Clinical Predictability Through Human Disease-Relevant Preclinical Models in CNS and Muscle Drug Discovery," to learn how an integrated, human-centric preclinical approach can give your pipeline clearer go/no-go answers and align early data with real-world clinical outcomes. 🎙️ Featured speakers Koji Murakami, Ph.D. and Tomonori Kitaura, DVM will be discussing: 🧠  Ways to leverage human iPSC-derived models and brain organoids to better mimic human neuropathology. 🎯  How to utilize EEG and microdialysis to directly link target engagement with true pharmacological effects. 🤖  Application of machine learning and AI-assisted tools to eliminate subjectivity in behavioral assessments. Register here to secure your spot: https://lnkd.in/gaaGd8NX

The FDA is formalizing a single-trial approval pathway, but as our latest Insights article breaks down, it does not lower the bar. If anything, it raises the stakes on trial design, statistical rigor, and the confirmatory evidence needed to bring a new drug to market. With less room for error, sourcing the right CROs, GMP manufacturing partners, and RWD providers becomes more important than ever. Scientist.com's procurement platform helps biopharma teams connect with pre-vetted suppliers who can execute complex trial designs and safeguard the integrity of a single pivotal study. 🧠  Learn more: https://lnkd.in/gsETtjUa

In case you missed it, the San Diego Business Journal recently ran an article on our new Innovation Hub, which brings together scientific webinars, podcasts, blogs, and industry insights directly onto Scientist.com. This year, we are on pace to facilitate more than $1 billion in research spend through our R&D orchestration platform—a reflection of the growing demand for faster, smarter, and more connected drug discovery processes. From simplifying procurement and supplier management to leveraging AI to streamline decision-making, we're focused on giving scientists more time to do what matters most: advancing discoveries that improve human health. Read the full article here: https://lnkd.in/gFSz4ntP

In an era of increasing disruptions caused by geopolitical shifts and tightening regulatory scrutiny, threats to the global pharmaceutical supply chain have never been more critical. Scientist.com and AGC Pharma Chemicals are tackling these challenges head-on by safeguarding the drug development pipeline. AGC has successfully completed an onsite assessment of its new Barcelona facility using Scientist.com’s VERIF.i® supplier pre-assessment program, establishing a blueprint for risk mitigation in global drug manufacturing among CDMOs. How This Collaboration Mitigates Threat Through Transparent Compliance: 🌐  Securing Global Compliance: AGC leveraged VERIF.i to transparently demonstrate adherence to international management standards, reinforcing quality globally. ☑️  De-risking the Vendor Network: VERIF.i uses independent, third-party auditors to provide pre-assessment insights, allowing pharmaceutical companies to evaluate vendors with confidence before supply chain bottlenecks occur. 💪 Strengthening R&D Resilience: Scientist.com’s R&D orchestration platform streamlines drug discovery by connecting scientists to a pre-qualified network of suppliers like AGC. Read the full press release here: https://lnkd.in/eV-s6dnd

Join us as we welcome Novalix for an upcoming webinar exploring how an integrated biophysical toolkit turns structural insights into a precision-driven strategy. What attendees will learn: 🔬 Practical Workflows: Master the fundamentals of combining Cryo-EM, X-ray, NMR, and HDX-MS. 📈  Strategic Mapping: Learn how to balance each technique's unique strengths and limitations. 🧑 Real-World Evidence: Review case studies where integrated approaches vastly outperformed single-method workflows. 🎯  Target Mastery: Discover how to unlock complex membrane proteins and challenging bimolecular interactions. Secure your spot now to learn how structural strategies are shaping the future of medicine: https://lnkd.in/eN7PU25R

Join Scientist.com and KACTUS for the upcoming webinar, "Visualizing Lipid Control of Drug Binding in Membrane Proteins at High Resolution". Featuring Dr. Ekundayo Babatunde (Scientist at EPFL), this session will cover how dynamic lipid environments actively dictate drug efficacy and binding modes. Our esteemed guest speaker will share breakthrough, high-resolution cryo-EM studies of a drug-bound TRP ion channel, demonstrating exactly how temperature-dependent remodeling of the annular lipid matrix directly regulates ligand-binding behavior. Learn how to integrate native lipid environments directly into your rational drug design workflows by registering here: https://lnkd.in/enJrFWQf

Check out the transformation of our storage room from post-conference chaos 📦 😵💫 to organized bliss. ✨  Spring conference season may be over, but our swag closet tells the real story. After a whirlwind of events—and more tote bags handed out than we'd like to admit—we've finally restocked, sorted, and reclaimed our storage area. Looking ahead to an already packed fall event season, we're curious: What's the best piece of conference swag you picked up this year? Drop your favorite swag item in the comments, as we're always looking for inspiration! And keep an eye out for the Scientist.com team in 2026. We've got some exciting things in the works!

Today, Scientist.com officially announced the upcoming breakthrough panel webinar: "New Approach Methodologies (NAMs): Key Considerations and Applications." At Scientist.com, our recently launched Innovation Hub is dedicated to tracking the latest developments in life science research. As the industry navigates the FDA’s evolving stance on non-animal testing models, this upcoming webinar is a prime example of the cutting-edge content we bring to our community to keep your pipelines ahead of the curve. During the session, the following experts will provide a practical blueprint for integrating advanced human-relevant systems into R&D processes: 🔬 BioIVT (Dr. Courtney Noah) will present on managing donor variability and ethical sourcing to guarantee regulatory acceptance. 🧫 HUB Organoids (Dr. René Overmeer) will present on an automated platform that miniaturizes patient-derived organoid screening down to a 1-week turnaround. 🤖 Cyprotex (Dr. Paul Walker) will present on leveraging high-throughput RNA-seq and AI/ML to detect multi-organ toxicity at the earliest stages. The regulatory shift toward human-centric, animal-free drug discovery data is officially here. Explore the next generation of regulatory science. 🔎  Read the full press release and register today: https://lnkd.in/eafexYti

I am so unbelievably proud of this moment. An idea that started at least 5 years ago has finally become reality. Thank you so much to so many people that brought this massive project together. For more background, read the full press release: https://lnkd.in/dT5z4FGE